Oxycodone And Acetaminophen
Product Images NDC 72022-583

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxycodone And Acetaminophen (NDC 72022-583). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Halo Pharmaceutical Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 mg/325 mg 100 Tablets (10mg 325mg Tabs 100 Nj)

This is a medication containing both Oxycodone Hydrochloride USP (10mg) and Acetaminophen, USP (325mg). The usual dosage information is available on the accompanying prescription. The packaging includes a child-resistant closure and it is recommended to store the container in a tight place between 20 to 25 degrees Celsius. The medication must be dispensed with the enclosed Medication Guide to each patient. The manufacturer is Promacantcal Company and this package contains 100 Tablets.*

FDA Label Image

10 mg/325 mg 500 Tablets (10mg 325mg Tabs 500 Nj)

This is a medication containing Oxycodone and Acetaminophen in a bulk package of 500 tablets. Each tablet has NDC 72022-584-05 and contains 325mg of USP acetaminophen and an equivalent of 8.9637mg of oxycodone. The usual dosage must be seen in the accompanying prescribing from the manufacturer Feroerionde. The tablets must be stored in a tight light-resistant container with child-resistant closure at 20° to 25°C. It contains a medication guide that should be dispensed to each patient. Multiple strengths are available, and it is essential to keep it out of children's reach. The manufacturer is Reonly sl prarmacauiave.*

FDA Label Image

5 mg/325 mg 100 Tablets (5mg 325mg Tabs 100 Nj)

This is a description for a pain-relief medication called "Noc," containing oxycodone and acetaminophen. Each tablet has 5mg oxycodone hydrochloride and 325 mg acetaminophen hydrochloride. The medication should be stored at room temperature in a light-resistant and child-resistant container. A medication guide must be given to each patient, and the medication should be kept out of the reach of children. The manufacturer is Pronmacental.*

FDA Label Image

5 mg/325 mg 500 Tablets (5mg 325mg Tabs 500 Nj)

FDA Label Image

7.5 mg/325 mg 100 Tablets (7,5mg 325mg Tabs 100 Nj)

This is a description of a pain medication that contains Hydrochloride (USP 7.5mg) and Acetaminophen (USP 325mg) in a tablet form. It is recommended to refer to the prescribing information for usual dosage, and the tablets need to be dispensed in a light-resistant, child-resistant container. It is important to store the medication in a controlled room temperature (20°to 25°C) and keep it out of reach of children. The enclosed medication guide should be given to every patient. The manufacturer is Vi-Whippany Pharmaceutical, and the medication is available in different strengths. The text also includes lot and expiration information.*

FDA Label Image

7.5 mg/325 mg 500 Tablets (7,5mg 325mg Tabs 500 Nj)

This is a medication containing Oxycodone Hydrochloride and Acetaminophen. It comes in the form of tablets with a dosage of 7.5mg and is equivalent to 6.7228mg of oxycodone. The usual dosage is to be determined by the prescribing doctor. It is recommended to store the tablets in a light-resistant container and to keep them out of reach of children. The medication guide should be given to each patient. The manufacturer of the medication is not specified.*

FDA Label Image

Acetaminophen Molecule (Acetaminophen Molecule)

This appears to be a chemical formula or molecular configuration. The formula is CgHsNO and the molecular weight is 151.17. It is not possible to determine the exact chemical compound based solely on this information.*

FDA Label Image

Oxycodone Molecule (Oxycodone Molecule)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.